3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Stomach Neoplasms
1
Adenocarcinoma
1
Interventions
pembrolizumab
117
Carboplatin
47
Nivolumab
46
Paclitaxel
34
Cyclophosphamide
34
Cisplatin
33
Gemcitabine
30
atezolizumab
28
Specimen Handling
26
venetoclax
25
Magnetic Resonance Spectroscopy
25
Docetaxel
24
fludarabine
23
Pemetrexed
23
Radiotherapy
22
Biopsy
22
Bevacizumab
22
Ipilimumab
21
Azacitidine
21
Dexamethasone
19
durvalumab
18
Radiosurgery
18
Fluorouracil
17
Cetuximab
16
Trastuzumab
15
fludarabine phosphate
14
Leucovorin
14
Cytarabine
14
tislelizumab
13
Lenalidomide
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
tegafur-gimeracil-oteracil
×
1 year
×
Clear all
NCT05161572
2025-06-18
NeoRacing
Fudan University
Phase 2
Terminated
6 enrolled